NewGenIvf prices $1.25 million public offering at $0.07 per share
NIVF•NewGenIvf priced a public offering targeting about $1.25 million in gross proceeds, with shares at $0.07 each; the closing is expected on or about Sept. 30, 2026.
1. Offering terms
The offering covers 17,857,143 ordinary shares or pre-funded warrants in lieu of shares. The warrants are priced at $0.06999 each and have an exercise price of $0.00001. Net proceeds are earmarked for a K25.ai investment, debt securities restructuring, working capital, Nodexus machine deployment and corporate purposes.
